ATE544852T1 - Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie - Google Patents

Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie

Info

Publication number
ATE544852T1
ATE544852T1 AT04770985T AT04770985T ATE544852T1 AT E544852 T1 ATE544852 T1 AT E544852T1 AT 04770985 T AT04770985 T AT 04770985T AT 04770985 T AT04770985 T AT 04770985T AT E544852 T1 ATE544852 T1 AT E544852T1
Authority
AT
Austria
Prior art keywords
drug
risk
assessing
induced granulocytopenia
kit
Prior art date
Application number
AT04770985T
Other languages
English (en)
Inventor
Koji Suematsu
Kouichi Hasegawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE544852T1 publication Critical patent/ATE544852T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04770985T 2003-07-29 2004-07-28 Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie ATE544852T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003281937 2003-07-29
PCT/JP2004/010722 WO2005010183A1 (ja) 2003-07-29 2004-07-28 薬剤起因性顆粒球減少症発症リスク判定法

Publications (1)

Publication Number Publication Date
ATE544852T1 true ATE544852T1 (de) 2012-02-15

Family

ID=34100975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04770985T ATE544852T1 (de) 2003-07-29 2004-07-28 Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie

Country Status (10)

Country Link
US (4) US7790372B2 (de)
EP (2) EP2275539B1 (de)
KR (2) KR101176191B1 (de)
CN (1) CN100482794C (de)
AT (1) ATE544852T1 (de)
AU (1) AU2004259952B2 (de)
CA (1) CA2530168C (de)
ES (2) ES2379811T3 (de)
TW (1) TWI351436B (de)
WO (1) WO2005010183A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090142766A1 (en) * 2007-11-09 2009-06-04 Washington University In St. Louis Methods for measuring the metabolism of cns derived biomolecules in vivo
US20110177509A1 (en) * 2008-07-23 2011-07-21 The Washington University Risk factors and a therapeutic target for neurodegenerative disorders
DK2519632T3 (en) * 2009-12-31 2018-07-23 Curna Inc TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2- (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPTION TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)
JP6381919B2 (ja) * 2014-01-24 2018-08-29 大塚製薬株式会社 化合物の無顆粒球症誘発性の評価方法
US10830775B2 (en) 2014-09-30 2020-11-10 Washington University Tau kinetic measurements
WO2020185916A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5732076A (en) * 1995-10-26 1998-03-24 Omnipoint Corporation Coexisting communication systems
ES2375764T3 (es) 1996-11-29 2012-03-06 Third Wave Technologies, Inc. Endonucleasas fen-1, mezclas y procedimientos de escisión.
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
JP2000279197A (ja) 1999-03-31 2000-10-10 Genome Science Laboratories Co Ltd Ｈｉｖの変異の検出方法
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20030040315A1 (en) * 2001-08-20 2003-02-27 Farideh Khaleghi Reduced state transition delay and signaling overhead for mobile station state transitions
US8958493B2 (en) * 2004-03-31 2015-02-17 Infineon Technologies Ag Operation for backward-compatible transmission
US7764981B2 (en) * 2004-07-30 2010-07-27 Nokia Corporation System and method for managing a wireless connection to reduce power consumption of a mobile terminal

Also Published As

Publication number Publication date
EP1650300A1 (de) 2006-04-26
EP2275539A2 (de) 2011-01-19
KR101176191B1 (ko) 2012-08-22
US8492087B2 (en) 2013-07-23
WO2005010183A1 (ja) 2005-02-03
US20070264631A1 (en) 2007-11-15
CA2530168C (en) 2014-05-27
TWI351436B (en) 2011-11-01
US7790372B2 (en) 2010-09-07
US20100273175A1 (en) 2010-10-28
TW200516152A (en) 2005-05-16
KR20060040600A (ko) 2006-05-10
ES2379811T3 (es) 2012-05-03
US20100273176A1 (en) 2010-10-28
KR101176194B1 (ko) 2012-08-22
AU2004259952B2 (en) 2008-10-16
US20140186826A1 (en) 2014-07-03
AU2004259952A1 (en) 2005-02-03
ES2391076T3 (es) 2012-11-21
EP2275539B1 (de) 2012-09-05
EP1650300B1 (de) 2012-02-08
CN100482794C (zh) 2009-04-29
KR20120068995A (ko) 2012-06-27
CA2530168A1 (en) 2005-02-03
EP2275539A3 (de) 2011-05-18
CN1833023A (zh) 2006-09-13
EP1650300A4 (de) 2007-08-22

Similar Documents

Publication Publication Date Title
WO2005035545A3 (en) Single nucleotide polymorphism analysis of highly polymorphic target sequences
DE602004015408D1 (de) Verfahren zur analyse von polymer-populationen
DE602004019941D1 (de) Verfahren für multiplex-polymerasekettenreaktionen auf hohem niveau und homogenen massenverlängerungsreaktionen zur genotypisierung von polymorphismen
ATE534753T1 (de) Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens
MY150648A (en) Hla alleles associated with adverse drug reactions and methods for detecting such
ATE481503T1 (de) Verfahren zur genotypisierung von antigenen von blutzellen und ein kit zur genotypisierung
BRPI0519570A2 (pt) mÉtodo de determinaÇço de faixa de dose de uma warfarina para um indivÍduo, kit para determinaÇço da faixa de dose de uma warfarina, oligonucleotÍdeo ou complemento do mesmo, e, arranjo de oligonucleotÍdeos
EP3318643A3 (de) Verfahren und zusammensetzungen zur identifizierung und behandlung von lupus
ATE491811T1 (de) Verfahren zum nachweis mutanter allele mit kombination von echtzeit-pcr und rems-pcr
WO2006055524A3 (en) Biomarkers for diagnosing schizophrenia and bipolar disorder
WO2008076856A3 (en) Reagents and methods for detecting cyp2d6 polymorphisms
EP1684202A4 (de) Verfahren zur bestimmung eines genetischen polymorphismus zur beurteilung eines grades der krankheitsgefahr, verfahren zur beurteilung des grades der krankheitsgefahr und beurteilungs-array
BRPI0416883A (pt) método e marcadores para determinação de genótipo de gado com chifre/mocho
DE112005001317A5 (de) Polymorphismen im NOD2/Card15 Gen
DK1791973T3 (da) DOT1-histonmethyltransferaser som et target til at identificere terapeutiske midler mod leukæmi
EP1650300A4 (de) Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie
DK1291427T3 (da) Fremgangsmåde til påvisning og kvantificering af humane P450-molekylspecies og probe og kit til denne fremgangsmåde
ATE554164T1 (de) Primer für nukleinsäureamplifikation bei der detektion von haushaltsgen-mrna und testverfahren unter verwendung der primer
EP1683862A4 (de) Mikroarray zur beurteilung der neuroblastomprognose und verfahren zur beurteilung der neuroblastomprognose
DE602004030036D1 (de) Multiplexanalyse von Nukleinsäuren zur Bestimmung von Genotypen des humanen Papillomavirus
DE602004030910D1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
EP1767652A4 (de) Genmarker und dessen verwendung
DE602004026439D1 (de) Lp-pla2-aktivitätstest mit hohem durchsatz
ATE432996T1 (de) Verfahren zur bestimmung des bodenzustands
ATE478964T1 (de) Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde